Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes-Reference-Cited by-同舟云学术

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes

Published:2018-04-11 Issue:3 Volume:9 Page:1099-1111
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Perez-Nieves Magaly,Boye Kristina S.,Kiljanski Jacek,Cao Dachung,Lage Maureen J.^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-018-0421-5.pdf

Reference52 articles.

1. American Diabetes Association. Statistics about diabetes [Internet]. 2017. http://www.diabetes.org/diabetes-basics/statistics/ . Accessed December 2017.

2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 [Internet]. Atlanta, GA: U.S. Department of Health and Human Services, Center for Disease Control and Prevention 2011. https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf . Accessed December 2017.

3. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36(4):1033–46.

4. American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment. Standards of medical care in diabetes—2018. Diabetes Care. 2018;41[Suppl 1]:S73–85.

5. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005–12.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating medication adherence among Taiwanese patient with hypertension, hyperlipidemia, and diabetes: A pilot study using the Chinese version of a Two-Part Medication Nonadherence Scale and the NHI MediCloud system;PLOS ONE;2024-07-10

2. Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials;Endocrinology, Diabetes & Metabolism;2024-04-24

3. Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis;BMJ Open Diabetes Research & Care;2024-03

4. Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes;Patient Preference and Adherence;2024-02

5. Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials;Journal of the Endocrine Society;2023-12-28